NOT-CA-23-077: Notice of Correction to Award Budget in RFA-CA-23-027 "Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)"

Notice of Correction to Award Budget in RFA-CA-23-027 "Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)"

Notice Number:

NOT-CA-23-077

Key Dates

Release Date:

July 10, 2023

Related Announcements

June 28, 2023: RFA-CA-23-027-Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional). See RFA-CA-23-027

Issued by

National Cancer Institute (NCI)

Purpose

This is a Notice of Correction to the Award Budget information in RFA-CA-23-027 "Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)"

The following section of RFA-CA-23-027 has been corrected:

Section II. Award Information

Currently Reads:

Award Budget

Application budgets are limited to $1.5 M in direct costs per year.

Modified to read (changes shown in italics):

Award Budget

Application budgets are limited to $500 K in direct costs per year.

All other aspects of RFA-CA-23-027 remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Amanda M. Acevedo, PhD
National Cancer Institute (NCI)
Telephone: 240-276-5896
Email: [email protected]

April Oh, PhD
National Cancer Institute (NCI)
Telephone: 240-753-3154
Email: [email protected]

Financial/Grants Management Contact(s)

Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: [email protected]